Article
Lipoprotein-associated phospholipase A2, C-reactive protein, and coronary artery disease in individuals with type 1 diabetes and macroalbuminuria.
Diabetes & vascular disease research - 1 Jan 2010
Miller Rachel G, Costacou Tina, Orchard Trevor J
Abstract excerpt
Given the paucity of data in type 1 diabetes concerning lipoprotein-associated phospholipase A( 2) (Lp-PLA(2)), we examined its prospective relationship with coronary artery disease (CAD), as well as the effect of modification by C-reactive protein (CRP) and haptoglobin genotype, in individuals with type 1 diabetes who are at an increased risk for CAD due to also having macroalbuminuria (n=96). Although Lp-PLA(2)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
